The ACT EU initiative aims to identify gaps, issues and bottlenecks (regulatory, resourcing, operational) that present challenges for non-commercial sponsors in the conduct of clinical trials and multinational trials in particular.
The programme intends to propose pragmatic and harmonised solutions to support non-commercial sponsors setting up and conducting clinical trials across the European Union / European Economic Area.

News

The ACT EU workplan for 2025-2026 outlines the initiative's areas of focus, which reflect feedback from stakeholders.

ACT EU has published two new webpages with information of interest to the network and clinical trial stakeholders.

Revised rules for Clinical Trials Information System (CTIS) become applicable.